3, 3′- (3, 5-DCPBC) Down-Regulates Multiple Phosphokinase Dependent Signal Transduction Pathways in Malignant Melanoma Cells through Specific Diminution of EGFRY1086 Phosphorylation

• Published in: Molecules (Basel, Switzerland) Vol. 27; no. 4; p. 1172
• Main Authors: Qurat-ul-Ain, Basu, Abhijit, Choudhary, M. Iqbal, Scharffetter-Kochanek, Karin
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 09.02.2022; MDPI
• Subjects: bis-coumarin; Cell growth; Coumarin; Epidermal growth factor; Epidermal growth factor receptors; Growth factors; Immunotherapy; Intracellular signalling; Kinases; Malignancy; Melanocytes; Melanoma; Metastases; migration; Oxidative stress; phosphokinases; Phosphorylation; Redox properties; Sarcoma; Signal transduction; Skin cancer; Src protein; Survival; Transcription factors; Tyrosine; tyrosine kinases; United States > US
• ISSN: 1420-3049; 1420-3049
• DOI: 10.3390/molecules27041172

Melanoma is the most dangerous skin malignancy due to its strong metastatic potential with high mortality. Activation of crucial signaling pathways enforcing melanoma progression depends on phosphorylation of distinct tyrosine kinases and oxidative stress. We here investigated the effect of a bis-coumarin derivative [3, 3′- ((3″, 5′-Dichlorophenyl) methylene) bis (4-hydroxy-2H-chromen-2-one)] [3, 3′- (3, 5-DCPBC)] on human melanoma cell survival, growth, proliferation, migration, intracellular redox state, and deciphered associated signaling pathways. This derivative is toxic for melanoma cells and non-toxic for melanocytes, their benign counterpart, and fibroblasts. 3, 3′- (3, 5-DCPBC) inhibits cell survival, migration, and proliferation of different metastatic and non-metastatic melanoma cell lines through profound suppression of the phosphorylation of Epidermal Growth Factor receptor (EGFR) and proto-oncogene cellular sarcoma (c-SRC) related downstream pathways. Thus, 3, 3′- (3, 5-DCPBC) endowed with the unique property to simultaneously suppress phosphorylation of multiple downstream kinases, such as EGFR/JAK/STAT and EGFR/SRC and their corresponding transcription factors.